Immunoglobulins to mitigate paraneoplastic Lambert Eaton Myasthenic Syndrome under checkpoint inhibition in Merkel cell carcinoma

التفاصيل البيبلوغرافية
العنوان: Immunoglobulins to mitigate paraneoplastic Lambert Eaton Myasthenic Syndrome under checkpoint inhibition in Merkel cell carcinoma
المؤلفون: Maike F. Dohrn, Simone C. Tauber, Jörg B. Schulz, Ulrike Schöne, Charlotte Küppers, Deborah Christen, Burkhard Gess
المصدر: Neurological Research and Practice
Neurological Research and Practice, Vol 2, Iss 1, Pp 1-3 (2020)
بيانات النشر: BioMed Central, 2020.
سنة النشر: 2020
مصطلحات موضوعية: biology, Merkel cell carcinoma, business.industry, Muscle weakness, medicine.disease, Immune checkpoint, lcsh:RC346-429, lcsh:RC321-571, Avelumab, Immune system, Antigen, Immunology, medicine, biology.protein, Antibody, medicine.symptom, business, Lambert-Eaton myasthenic syndrome, lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry, Letter to the Editor, lcsh:Neurology. Diseases of the nervous system, medicine.drug
الوصف: Lambert-Eaton myasthenic syndrome (LEMS) is a rare, autoimmune or paraneoplastic condition characterized by muscle weakness and fatigability. In cancer therapy, immune checkpoint inhibitors (ICI) sensitize the immune system for tumor antigens.We report a 62-year-old, female patient with paraneoplastic LEMS as first manifestation of Merkel cell carcinoma. Under avelumab, the LEMS exacerbated with worsening of limb weakness and a severely reduced vital capacity (This is the first description of paraneoplastic LEMS, avelumab, and Merkel cell carcinoma. We conclude that immunoglobulins are an option to control an ICI-associated deterioration of paraneoplastic symptoms.
اللغة: English
تدمد: 2524-3489
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad9daa87ac8157eee61c7e4dcb6e42b0Test
http://europepmc.org/articles/PMC7727206Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....ad9daa87ac8157eee61c7e4dcb6e42b0
قاعدة البيانات: OpenAIRE